Dr. Reddy's Laboratories (RDY) net assets (shareholders' equity)

Net assets · fiscal 2026
₹377.06B

Dr. Reddy's Laboratories (RDY) had net assets of ₹377.06B at the end of fiscal 2026 (March 31, 2026). That is 13.1% higher than the ₹333.39B of fiscal 2025. Figures as of 19 Nov 2026, 00:03 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2026
₹377.06B
Change on fiscal 2025
+13.1%
Highest on record
₹377.06Bfiscal 2026
Lowest on record
₹230.99Bfiscal 2023
Fiscal years on record
42023–2026

Figures as of . Statements from Yahoo Finance. Amounts are in INR. Figures, not advice.

Dr. Reddy's Laboratories net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2023–2026), the highest was ₹377.06B in fiscal 2026 and the lowest ₹230.99B in fiscal 2023.

History · 4 fiscal years

Net assets by fiscal year

Dr. Reddy's Laboratories net assets (shareholders' equity), year by year

Dr. Reddy's Laboratories (RDY) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2026₹377.06B 13.1% up
2025₹333.39B 18.8% up
2024₹280.55B 21.5% up
2023₹230.99B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Dr. Reddy's Laboratories and comparable companies
CompanyNet assetsFiscal year
Smith & Nephew SNN$5.29B2025
Penumbra PEN$1.43B2025
Dr. Reddy's Laboratories RDY₹377.06B2026
Align Technology ALGN$4.05B2025
Cooper Companies COO$8.24B2025
Fresenius Medical Care FMS€13.31B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RDY

Dr. Reddy's Laboratories, figure by figure

Dr. Reddy's Laboratories (RDY) overview: price, valuation and scorecardAll health care companies by market value

Dr. Reddy's Laboratories net assets (shareholders' equity): questions and answers

What are Dr. Reddy's Laboratories's net assets?

Dr. Reddy's Laboratories (RDY) had net assets of ₹377.06B at the end of fiscal 2026 (March 31, 2026). That is 13.1% higher than the ₹333.39B of fiscal 2025.

What are the highest and lowest net assets figures on record for Dr. Reddy's Laboratories?

Across the 4 fiscal years on record (2023–2026), the highest was ₹377.06B in fiscal 2026 and the lowest ₹230.99B in fiscal 2023.

How is Dr. Reddy's Laboratories's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Dr. Reddy's Laboratories it is on record here for 4 fiscal years, 2023 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Dr. Reddy's Laboratories (RDY) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/RDY/net-assets

Underlying data: Yahoo Finance.